Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2537 Views
-
Last post by NHE
-
- 0 Replies
- 23 Views
-
Last post by NHE
-
- 6 Replies
- 7319 Views
-
Last post by ElliotB
-
- 0 Replies
- 3757 Views
-
Last post by NHE
-
- 0 Replies
- 1415 Views
-
Last post by NHE
-
- 0 Replies
- 31 Views
-
Last post by NHE
-
- 0 Replies
- 3457 Views
-
Last post by NHE
-
- 11 Replies
- 3527 Views
-
Last post by NHE
-
- 1 Replies
- 1142 Views
-
Last post by NHE